Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

Pneumonia II: Pathophysiology

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:

Atypical Pneumonia

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...

Pneumothorax II: Pathophysiology

Pneumothorax II: Pathophysiology

Pneumothorax means the presence of air in the pleural space — the thin potential gap between the visceral and parietal pleura. This condition disrupts the normal pressure balance that keeps the lungs inflated, leading to partial or complete collapse of the affected lung.Normal physiologyUnder normal conditions, the pleural space maintains a slightly negative intrapleural pressure, which keeps the lungs expanded against the chest wall. This negative pressure creates a delicate balance between...

Other Pulmonary Disorders

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A Case of Exuberant Type 2 Pneumocyte Hyperplasia in a Young Man with Recurrent Spontaneous Pneumothorax: A Diagnostic Pitfall.

Surgical case reports·2026

Same author

Narrative review of descending necrotizing mediastinitis, focusing on the etiology, classification-guided surgical management, treatments, and prognosis.

Mediastinum (Hong Kong, China)·2026

Same author

Strangulated Small Bowel Obstruction Involving the External Iliac Artery after Pelvic Lymph Node Dissection: A Case Report on Stepwise Intraoperative Decision-Making to Prevent Vascular Injury.

Surgical case reports·2026

Same author

Intraoperative mobile CT and virtual-assisted lung mapping for pulmonary nodule localization: workflow characteristics and radiation dosage in a single-center experience.

General thoracic and cardiovascular surgery·2026

Same author

Main pulmonary artery reconstruction during lung transplantation for idiopathic pulmonary artery hypertension with giant pulmonary artery aneurysm.

JTCVS techniques·2026

Same author

Revisiting static ice storage in clinical lung transplantation: Direct and continuous temperature monitoring of donor lungs followed by mathematical modeling.

JHLT open·2026

Search research articles

Related Experiment Video

Updated: May 27, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

[Interstitial pneumonitis].

Fumihiko Hirai¹, Gouji Toyokawa, Taro Ohba

¹Dept. of Thoracic Oncology, National Kyushu Cancer Center, Japan.

Gan to Kagaku Ryoho. Cancer & Chemotherapy

|November 16, 2011

Summary

Managing interstitial pneumonitis risk during cancer chemotherapy requires a four-step approach. Early detection and medical staff cooperation are crucial for minimizing this adverse event.

More Related Videos

Experimental Model to Evaluate Resolution of Pneumonia

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

The Utilization of Oropharyngeal Intratracheal PAMP Administration and Bronchoalveolar Lavage to Evaluate the Host Immune Response in Mice

The Utilization of Oropharyngeal Intratracheal PAMP Administration and Bronchoalveolar Lavage to Evaluate the Host Immune Response in Mice

Published on: April 2, 2014

Related Experiment Videos

Last Updated: May 27, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

Experimental Model to Evaluate Resolution of Pneumonia

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

The Utilization of Oropharyngeal Intratracheal PAMP Administration and Bronchoalveolar Lavage to Evaluate the Host Immune Response in Mice

The Utilization of Oropharyngeal Intratracheal PAMP Administration and Bronchoalveolar Lavage to Evaluate the Host Immune Response in Mice

Published on: April 2, 2014

Area of Science:

Oncology
Pulmonology
Clinical Pharmacy

Background:

Interstitial pneumonitis is a serious adverse event associated with cancer chemotherapy.
Effective risk management strategies are essential to mitigate patient harm.

Purpose of the Study:

To outline a comprehensive, multi-step approach for managing the risk of interstitial pneumonitis in cancer patients.
To emphasize the importance of proactive measures throughout the chemotherapy treatment continuum.

Main Methods:

A four-step risk management framework is proposed, covering distinct phases of cancer treatment.
The framework integrates patient selection, treatment administration, follow-up, and event management.

Main Results:

Risk management involves proactive steps before, during, and after chemotherapy.
Coordinated efforts among the entire medical staff are vital for successful implementation.

Conclusions:

A systematic, four-phase approach is necessary for effective interstitial pneumonitis risk management.
Interdisciplinary collaboration is key to reducing the incidence and severity of this chemotherapy-related complication.